A Randomized Clinical Trial of the Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in Patients with Type 2 Diabetes Mellitus and Mild Renal Insufficiency: The CompoSIT ‐R Study

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - July 18, 2018 Category: Endocrinology Authors: Russell Scott MD, PhD , Jerry Morgan BS , Zachary Zimmer PhD , Raymond L.H. Lam PhD , Edward A. O ’Neill PhD , Keith D. Kaufman MD , Samuel S. Engel MD , Annaswamy Raji MD Source Type: research